NERM
New England Research & Management Portfolio holdings
AUM
$211M
This Quarter Return
+2.45%
1 Year Return
+11.93%
3 Year Return
+33.34%
5 Year Return
+70.28%
10 Year Return
+109.67%
AUM
$147M
AUM Growth
+$147M
(-0.44%)
Cap. Flow
-$4.85M
Cap. Flow
% of AUM
-3.29%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
189
New
25
Increased
30
Reduced
84
Closed
26
Top Buys
| 1 |
RTX Corp
RTX
|
$1.26M |
| 2 |
Eli Lilly
LLY
|
$1.02M |
| 3 |
Charles River Laboratories
CRL
|
$990K |
| 4 |
Lennar Class A
LEN
|
$962K |
| 5 |
UnitedHealth
UNH
|
$933K |
Top Sells
| 1 |
Azenta
AZTA
|
$2.06M |
| 2 |
McCormick & Company Non-Voting
MKC
|
$1.41M |
| 3 |
Vulcan Materials
VMC
|
$1.17M |
| 4 |
Valero Energy
VLO
|
$1M |
| 5 |
Acuity Brands
AYI
|
$966K |
Sector Composition
| 1 | Healthcare | 20.14% |
| 2 | Industrials | 16.02% |
| 3 | Technology | 14.42% |
| 4 | Consumer Staples | 13.67% |
| 5 | Financials | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Skyworks Solutions
SWKS
$10.8B
| $365K | 0.25% |
4,725
-6,650
| -58% | -$514K |
|
127
Northrop Grumman
NOC
$84.2B
| $355K | 0.24% |
1,100
-1,225
| -53% | -$395K |
|
128
Schlumberger
SLB
$53.4B
| $353K | 0.24% |
8,874
| – | – |
|
129
Toll Brothers
TOL
$13.3B
| $346K | 0.23% |
9,450
-850
| -8% | -$31.1K |
|
130
Edwards Lifesciences
EW
$48B
| $323K | 0.22% |
+1,750
| New | +$323K |
|
131
Elanco Animal Health
ELAN
$8.86B
| $321K | 0.22% |
+9,500
| New | +$321K |
|
132
Freeport-McMoran
FCX
$64.3B
| $319K | 0.22% |
27,500
-8,700
| -24% | -$101K |
|
133
Kimco Realty
KIM
$15B
| $305K | 0.21% |
+16,500
| New | +$305K |
|
134
Walmart
WMT
$779B
| $305K | 0.21% |
2,762
| – | – |
|
|
RTN
135
DELISTED
Raytheon Company
RTN
| $304K | 0.21% |
1,750
-700
| -29% | -$122K |
|
136
Ciena
CIEN
$13.1B
| $303K | 0.21% |
7,375
-4,025
| -35% | -$165K |
|
137
NextEra Energy, Inc.
NEE
$149B
| $287K | 0.19% |
1,400
| – | – |
|
138
Comcast
CMCSA
$126B
| $281K | 0.19% |
6,646
| – | – |
|
139
HealthEquity
HQY
$7.71B
| $277K | 0.19% |
+4,240
| New | +$277K |
|
140
BioMarin Pharmaceuticals
BMRN
$11.3B
| $270K | 0.18% |
3,150
-350
| -10% | -$30K |
|
141
NVIDIA
NVDA
$4.13T
| $264K | 0.18% |
1,610
-790
| -33% | -$130K |
|
|
HSBC.PRA
142
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
| $254K | 0.17% |
9,700
| – | – |
|
143
Coterra Energy
CTRA
$18.8B
| $250K | 0.17% |
+10,900
| New | +$250K |
|
144
Alaska Air
ALK
$7.13B
| $246K | 0.17% |
3,850
-1,225
| -24% | -$78.3K |
|
145
AstraZeneca
AZN
$248B
| $244K | 0.17% |
5,907
| – | – |
|
146
CME Group
CME
$95B
| $239K | 0.16% |
1,230
-275
| -18% | -$53.4K |
|
147
Intuit
INTU
$184B
| $235K | 0.16% |
+900
| New | +$235K |
|
148
Broadcom
AVGO
$1.4T
| $230K | 0.16% |
+800
| New | +$230K |
|
|
SIVB
149
DELISTED
SVB Financial Group
SIVB
| $230K | 0.16% |
1,025
-150
| -13% | -$33.7K |
|
150
Albemarle
ALB
$9.36B
| $225K | 0.15% |
3,200
-1,850
| -37% | -$130K |
|